abatacept vs diclofenac

PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.

Side-by-side comparison of abatacept and diclofenac. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
abatacept T-Cell Co-Stimulation Modulator
diclofenac Nonsteroidal Anti-Inflammatory Drug (NSAID)
Type
abatacept Prescription
diclofenac Over-the-Counter
Summary
abatacept

Orencia is a medicine that helps to reduce inflammation. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis.

diclofenac

Diclofenac is a gel that helps with arthritis pain in your hands, wrists, elbows, feet, ankles, or knees. It belongs to a class of drugs called NSAIDs.

What It Treats
abatacept

Orencia treats rheumatoid arthritis in adults. It also treats polyarticular juvenile idiopathic arthritis in patients 2 years and older. Orencia can also treat active psoriatic arthritis in patients 2 years and older. Finally, it can prevent acute graft versus host disease after a stem cell transplant.

diclofenac

This medicine temporarily relieves arthritis pain. It is only for pain in your hands, wrists, elbows, feet, ankles, or knees. It may take up to 7 days to start working. If you still have pain after 7 days, stop using it.

How It Works
abatacept

Orencia works by blocking the activity of certain immune cells called T cells. These T cells can cause inflammation and damage to your joints and other tissues. By blocking T cell activity, Orencia can help reduce inflammation and relieve your symptoms.

diclofenac

Diclofenac is an NSAID. It reduces pain and swelling by blocking substances in the body that cause inflammation.

Common Side Effects
abatacept
  • Headache
  • Upper respiratory tract infection (like a cold)
  • Runny nose
  • Nausea
diclofenac
  • Pain
  • Headache
FAERS Reports
abatacept
  • Rheumatoid Arthritis 23,596
  • Pain 21,295
  • Arthralgia 20,151
  • Joint Swelling 19,709
  • Fatigue 14,200
diclofenac
  • Pain 12,281
  • Fatigue 11,317
  • Rheumatoid Arthritis 9,241
  • Rash 8,747
  • Arthralgia 8,640
Serious Warnings
abatacept

Using Orencia with a TNF antagonist or other biologic medicines can raise your risk of serious infections. Tell your doctor if you have any signs of infection, such as fever, cough, or sore throat. Orencia can also cause allergic reactions, including anaphylaxis. Get medical help right away if you have trouble breathing, swelling, or hives.

diclofenac

No specific warnings noted.

Pregnancy
abatacept

There is not enough information about Orencia use in pregnant women to know if it is safe. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

diclofenac

No pregnancy information available.

Also Compare, Nearby Drugs

How to Read This abatacept vs diclofenac Comparison

abatacept is classified in the T-Cell Co-Stimulation Modulator drug class, while diclofenac sits within the Nonsteroidal Anti-Inflammatory Drug (NSAID) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abatacept has 98,951 submissions while diclofenac has 50,226. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for abatacept or diclofenac.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.